Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
A selection of articles from the 2014 issue of Turning Point.
To see the entire publication, please
download the PDF version. If you'd like to receive a print version of Turning Point in the mail, please
complete this form.
Researchers look for new ways to treat cancers caused by the HER2 and HER3 proteins
Recent advances enable a personalized approach to breast cancer surgery
Testing a new generation of targeted therapies for breast and gynecologic cancers
A young woman benefits from advanced radiation therapy for invasive cervical cancer
Turning Point is published for supporters of the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute.
Comments, suggestions, and requests to be added to or deleted from the mailing list may be sent to:
Dana-Farber Cancer Institute
Department of Communications
450 Brookline Ave.
Boston, MA 02215
Posted on May 29, 2014
For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to firstname.lastname@example.org.
Request a Publication
Receive by mail the current issue of a Dana-Farber publication by completing this request form.